Cytokines in cancer immunotherapy
TA Waldmann - Cold Spring Harbor perspectives in …, 2018 - cshperspectives.cshlp.org
Cytokines that control the immune response were shown to have efficacy in preclinical
murine cancer models. Interferon (IFN)-α is approved for treatment of hairy cell leukemia …
murine cancer models. Interferon (IFN)-α is approved for treatment of hairy cell leukemia …
The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines
PJ Austin, G Moalem-Taylor - Journal of neuroimmunology, 2010 - Elsevier
In a large proportion of individuals nervous system damage may lead to a debilitating
chronic neuropathic pain. Such pain may now be considered a neuro-immune disorder …
chronic neuropathic pain. Such pain may now be considered a neuro-immune disorder …
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models
C Hotz, TR Wagenaar, F Gieseke, DS Bangari… - Science translational …, 2021 - science.org
Local immunotherapy ideally stimulates immune responses against tumors while avoiding
toxicities associated with systemic administration. Current strategies for tumor-targeted …
toxicities associated with systemic administration. Current strategies for tumor-targeted …
Discovery of VH domains that allosterically inhibit ENPP1
PE Solomon, CJ Bracken, JA Carozza, H Wang… - Nature chemical …, 2024 - nature.com
Abstract Ectodomain phosphatase/phosphodiesterase-1 (ENPP1) is overexpressed on
cancer cells and functions as an innate immune checkpoint by hydrolyzing extracellular …
cancer cells and functions as an innate immune checkpoint by hydrolyzing extracellular …
Hepatotoxicity of chemotherapy
PD King, MC Perry - The oncologist, 2001 - academic.oup.com
After assessment of tumor histology, the next important factor to consider in the selection of a
chemotherapy regime is organ function. Patients who are to receive chemotherapy require …
chemotherapy regime is organ function. Patients who are to receive chemotherapy require …
The cytokine network
FR Balkwill, F Burke - Immunology today, 1989 - cell.com
These charts are primarily for reference but they allow US to make some preliminary
conclusions abotit the cflokine network:(l) Ail the cytokines in this list have growth factor …
conclusions abotit the cflokine network:(l) Ail the cytokines in this list have growth factor …
Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy
Tumour-associated neutrophils can exert antitumour effects but can also assume a pro-
tumoural phenotype in the immunosuppressive tumour microenvironment. Here we show …
tumoural phenotype in the immunosuppressive tumour microenvironment. Here we show …
Exercise and multiple sclerosis
LJ White, RH Dressendorfer - Sports medicine, 2004 - Springer
The pathophysiology of multiple sclerosis (MS) is characterised by fatigue, motor weakness,
spasticity, poor balance, heat sensitivity and mental depression. Also, MS symptoms may …
spasticity, poor balance, heat sensitivity and mental depression. Also, MS symptoms may …
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
AL Pecora, N Rizvi, GI Cohen, NJ Meropol… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: PV701, a replication-competent strain of Newcastle disease virus, causes
regression of tumor xenografts after intravenous administration. This phase I study was …
regression of tumor xenografts after intravenous administration. This phase I study was …
Cytokine therapeutics: lessons from interferon alpha.
JU Gutterman - Proceedings of the National Academy of …, 1994 - National Acad Sciences
Cytokines are soluble proteins that allow for communication between cells and the external
environment. Interferon (IFN) alpha, the first cytokine to be produced by recombinant DNA …
environment. Interferon (IFN) alpha, the first cytokine to be produced by recombinant DNA …